We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$10.1B
AUM Growth
-$32.7M
Cap. Flow
-$129M
Cap. Flow %
-1.28%
Top 10 Hldgs %
46.32%
Holding
595
New
41
Increased
67
Reduced
176
Closed
32

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$19.8M
2
HDB icon
HDFC Bank
HDB
+$13.2M
3
FISV
Fiserv Inc
FISV
+$10.3M
4
PYPL icon
PayPal
PYPL
+$9.75M
5
MSFT icon
Microsoft
MSFT
+$9.65M

Sector Composition

Rank Sector Weight
1 Technology 38.51%
2 Healthcare 17.03%
3 Consumer Discretionary 10.46%
4 Financials 10.36%
5 Communication Services 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
451
AstraZeneca
AZN
$246B
$22.3K ﹤0.01%
159
NWL icon
452
Newell Brands
NWL
$2.62B
$22.1K ﹤0.01%
3,184
VTR icon
453
Ventas
VTR
$45.7B
$21.6K ﹤0.01%
500
CASY icon
454
Casey's General Stores
CASY
$31B
$21K ﹤0.01%
+67
New +$19.6K
BABA icon
455
Alibaba
BABA
$300B
$20.6K ﹤0.01%
292
VSS icon
456
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
$20.5K ﹤0.01%
181
+47
+35% +$5.32K
KD icon
457
Kyndryl
KD
$2.85B
$20.2K ﹤0.01%
1,013
TROW icon
458
T. Rowe Price
TROW
$23.8B
$20.1K ﹤0.01%
180
-500
-74% -$55.8K
EPAM icon
459
EPAM Systems
EPAM
$5.17B
$19.8K ﹤0.01%
80
PFF icon
460
iShares Preferred and Income Securities ETF
PFF
$13.3B
$19.7K ﹤0.01%
+635
New +$20.2K
BIDU icon
461
Baidu
BIDU
$35.6B
$19.4K ﹤0.01%
200
FMS icon
462
Fresenius Medical Care
FMS
$12.6B
$19K ﹤0.01%
926
IBB icon
463
iShares Biotechnology ETF
IBB
$9.86B
$18.9K ﹤0.01%
150
ICE icon
464
Intercontinental Exchange
ICE
$85B
$18.8K ﹤0.01%
143
+60
+72% +$7.97K
AAXJ icon
465
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.83B
$18.1K ﹤0.01%
273
EEM icon
466
iShares MSCI Emerging Markets ETF
EEM
$30.4B
$18.1K ﹤0.01%
450
PHO icon
467
Invesco Water Resources ETF
PHO
$2.06B
$17.8K ﹤0.01%
280
WTS icon
468
Watts Water Technologies
WTS
$12.9B
$17.2K ﹤0.01%
84
CSGP icon
469
CoStar Group
CSGP
$12.4B
$17.1K ﹤0.01%
200
+120
+150% +$10.3K
BNTX icon
470
BioNTech
BNTX
$23.3B
$16.7K ﹤0.01%
190
GPC icon
471
Genuine Parts
GPC
$18.5B
$16.6K ﹤0.01%
102
+35
+52% +$5.1K
WBD icon
472
Warner Bros
WBD
$69.3B
$15.9K ﹤0.01%
1,875
-834
-31% -$8.04K
ABNB icon
473
Airbnb
ABNB
$108B
$15.7K ﹤0.01%
100
SOLV icon
474
Solventum
SOLV
$14.5B
$15.5K ﹤0.01%
+249
New +$18.6K
NOVA
475
DELISTED
Sunnova Energy
NOVA
$15.3K ﹤0.01%
+4,000
New +$36.1K

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Loring Wolcott & Coolidge Fiduciary Advisors held 595 positions worth $10.1B, down 0.32% from $10.1B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2024 filing shows 41 new, 67 increased, 176 reduced and 32 closed positions. Its largest new stake was GE Vernova: 3,494 shares worth $478K. The largest sale was Mastercard, an estimated $19.8M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2024 buy was GE Vernova: 3,494 shares worth $478K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Regeneron Pharmaceuticals in Q1 2024, an estimated $24.6M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2024 reduction was Mastercard, cutting an estimated $19.8M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Wheaton Precious Metals in Q1 2024, selling an estimated $497K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 46% of its $10.1B portfolio in Q1 2024.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 41 new positions and closed 32 in Q1 2024.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 0.32% quarter-over-quarter to $10.1B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.